All In MedTech

FDA Clearance Tracker · P080025-S148

InterStim® Sacral Nerve Stimulation Therapy System / Bowel Control

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 7, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 7, 2018

Approved

Time to decision

170 days

Received Aug 21, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P080025-S148
Device name
InterStim® Sacral Nerve Stimulation Therapy System / Bowel Control
Applicant location
Minneapolis, MN
Received
Aug 21, 2017
Decided
Feb 7, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P080025

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code QON

FDA's approval statement

As written in FDA's record.

Approval for labeling updates to incorporate 5 year data from the InSite Post-Approval Study (Single Tined Lead (protocol 1634).

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.